Validation of a cancer population derived AKI machine learning algorithm in a general critical care scenario.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Published Date:

Abstract

PURPOSE: Acute Kidney Injury (AKI) is the sudden onset of kidney damage. This damage usually comes without warning and can lead to increased mortality and inpatient costs and is of particular significance to patients undergoing cancer treatment. In previous work, we developed a machine learning algorithm to predict AKI up to 30 days prior to the event, trained on cancer patient data. Here, we validate this model on non-cancer data.

Authors

  • Lauren Abigail Scanlon
    Clinical Outcomes and Data Unit, The Christie NHS Foundation Trust, Manchester, M20 4BX, UK. l.scanlon@nhs.net.
  • Catherine O'Hara
    Clinical Outcomes and Data Unit, The Christie NHS Foundation Trust, Manchester, M20 4BX, UK.
  • Matthew Barker-Hewitt
    Clinical Outcomes and Data Unit, The Christie NHS Foundation Trust, Manchester, M20 4BX, UK.
  • Jorge Barriuso
    Division of Cancer Sciences, Manchester Cancer Research Centre, The University of Manchester, Manchester, M13 9PL, UK.